Breast cancer is the most common cancer in women, with 55k new cases in the UK each year. Aggressive treatment strategies have doubled breast cancer survival rates since the 1970s, but it’s now recognised that many of these patients are over-treated. Cambridge-led clinical trials showed that reducing radiation and drug therapy in qualifying patients spared them from unnecessary side effects, preserved excellent survival rates and reduced treatment costs. This led to a change in practice across the UK and globally.
Added 14 November 2022